You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 1, January 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TREATMENT OF HERPES ZOSTER OPHTHALMICUS WITH CORTISONE OR CORTICOTROPIN

HAROLD G. SCHEIE, M.D.; MELVIN C. ALPER, M.D.

AMA Arch Ophthalmol. 1955;53(1):38-44.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS PAPER presents observations on the treatment of herpes zoster ophthalmicus in 11 patients, all of whom had ocular involvement, by cortisone or corticotropin given systemically. Relief of pain was generally prompt. Striking improvement was usually noted in the ocular lesions. Final visual results were highly encouraging.

From 1937 to 1945, our results had been extremely discouraging in this type of disease. Partial or complete loss of vision, as a result of secondary glaucoma or corneal opacity, was not infrequent. In 1945, in view of the excellent results reported by Friedenwald1 and Gundersen,* we began to employ immune serum therapeutically, with what seemed to be a more favorable outcome. In a group of patients, comparable in size to our present series, no impairment of vision resulted. The treatment of herpes zoster ophthalmicus with immune serum, however, involves certain difficulties. Frequent transfusions are necessary, necessitating a number of donors, who . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

From the Department of Ophthalmology, Hospital of the University of Pennsylvania.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.